ASSESSMENT OF KIDNEY INJURY DURING IMMUNE-TARGETED THERAPY (PEMBROLIZUMAB + AXITINIB) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AND SOLITARY KIDNEY ArticleTitov Konstantin Sergeevich, Epifanova M.V., Alimov Artemy Andreevich, Shutov Evgeniy Viktorovich, Nesterova Olga Yu, Lebedev Sergey S., Zapirov Gadzhimurad MagomedovichOnkourologiya. Том 21. 2025. С. 33-41
